Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Exclusion criteria includes patients previously treated for cancer."

That makes absolutely no sense, even to this science bozo.

"Oral mucositis is probably the most common, debilitating complication of cancer treatments, particularly chemotherapy and radiation."
http://www.oralcancerfoundation.org/complications/mucositis.php

They want to test Brilacidin's effectiveness in treating a side effect to cancer treatments in patients that haven't had any cancer treatments? Meanwhile leaving the cancer itself untreated?

What am I missing?